INNOVEX THERAPEUTICS S.L. (ITSL) is the first Spanish Company that is focused on development of Exosomes and Extracellular Vesicles as new platforms for vaccines and diagnostic tools. The company was founded in March 2014 by researchers from the field of vesicles and exosomes and have industry experts in advisory roles. This approach is internationally protected  (PCT/EP2010/070800).

INNOVEX THERAPEUTICS S.L. is a brand new Spin-off co-founded by Hernando A del Portillo and Francesc E. Borrás, with 10% accionary participation of three Research Institutions:

icrea  Institució Catalana de Recerca i Estudis Avançats

igtp  Institut for Biomedical Research “Germans Trias i Pujol”

ISGlobal_logo_es  Instituto de salud Global Barcelona





Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s